— Third quarter revenues of $2.82 billion, up 13.1% from 2024 — Third quarter reported diluted earnings per share (“EPS”) of $2.16, up 8.5% from 2024; and adjusted diluted EPS of $2.60, up 13.0% from 2024 — Year-to-date cash provided by operations of $1.4 billion, up 63.1% from 2024 — Full year 2025 reported diluted […]
The Wellness revenue table has been updated to reflect accurate figures for Q3 2025. No impact to Group consolidated results or commentary. LONDON, GB / ACCESS Newswire / October 21, 2025 / Physitrack PLC (STO:PTRK) – Fourth Consecutive Quarter of Resilient, Cash-Generative Growth, Marking Historical Positive Cash flow. Investor snapshot Metric Q3 2025 Q3 2024
IASO Biotherapeutics (“IASO Bio”), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announcedthe Clinical Trial Notification (CTN) for its independently developed fully human anti-BCMA CAR-T cell therapy was approved in Japan. The approval of the CTN in Japan for this product indicates that Japanese regulatory authorities have
Unitil Schedules Third Quarter 2025 Earnings Release and Conference Call GlobeNewswire October 21, 2025 HAMPTON, N.H., Oct. 21, 2025 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its third quarter 2025 earnings after the market closes on November 3, 2025. Unitil will host its conference call and webcast on November
Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to announce a new strategic partnership between Bybit Payand Idram, Armenia's established financial service provider and digital payment powerhouse. The integration underscores Bybit Pay's unwavering commitment to building crypto's global payment rails through incremental, localized initiatives that bring real-life benefits to digital asset holders.
(NYSE:NOC), FALLS CHURCH, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its third quarter 2025 financial results. A copy of the earnings release has been furnished in the company's Form 8-K filing and is also available on the company's investor relations website at http://investor.northropgrumman.com. Earnings Call Webcast As previously
Northrop Grumman Releases Third Quarter 2025 Financial Results GlobeNewswire October 21, 2025 FALLS CHURCH, Va., Oct. 21, 2025 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its third quarter 2025 financial results. A copy of the earnings release has been furnished in the company's Form 8-K filing and is also available on the
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of MoonLake Immunotherapeutics ("MoonLake") (NASDAQ:MLTX) concerning possible violations of federal securities laws. On September 29, 2025, MoonLake announced that its experimental
— New research from the Competere Foundation shows the U.S. could lose an estimated $525B; Korean economy, small businesses would suffer $469B in losses. — The US and Korea are negotiating a trade deal to lower the high tariff imposed on Korea by the US. Reforms to Korea's regulatory culture could be a landing zone